Pharma news

Updated pharma, healthcare and biotech news.

First-ever Peanut allergy treatment; Dinutuximab misses primary endpoint; Insmed’s shares Soares

Business Consultant, Pharma Consultant, Pharma news

The US FDA has given its recommendation to the Aimmune Therapeutics’ drug, Palforzia, the first-ever treatment for Peanut Allergy....

Read More

Annovis announces IPO results; Conatus merges with Histogen; Novartis discontinues its generic journey

Business Consultant, Pharma Consultant, Pharma news

A Philadelphia-based pharmaceutical, Annovis Bio, has raised USD12 million by listing its 2 million shares at USD 6 each. The company has...

Read More

Tepezza receives approval; a new way to treat Alzheimer’s

Business Consultant, Pharma Consultant, Pharma news

Horizon Therapeutics has become the first company to receive the regulatory approval of its drug Tepezza for the cure of Thyroid Eye...

Read More

Thumbs down to NKTR-181, Lilly expands its insulin armamentarium

Business Consultant, Pharma Consultant, Pharma news

The US FDA has voted down Nektar Therapeutics’ opioid painkiller NKTR-181, designed to treat lower back pain.  The FDA’s...

Read More

Novome raises USD 33M, Buyout of Bioniz, Adagene raises USD 69M

Business Consultant, Pharma Consultant, Pharma news

A biotech company Novome Biotechnologies is developing novel live medicines for chronic diseases, has raised USD 33 Million in Series A...

Read More

Nunaps raises USD 4.2M; Arcutis files for USD 100M IPO

Business Consultant, Pharma Consultant, Pharma news

A South Korean startup therapeutics company Nunaps has successfully raised USD 4.2 Million around 5 billion won in a Series A round. ...

Read More
Close